What is RxWare worth?
$19.5Mlast known valuation
RxWare last raised $6.1M in its Early Stage VC (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for RxWare
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Early Stage VC | $6.1M | ▮ | ▮ |
| Apr 2024 | Seed Round | $700K | ▮ | ▮ |
How RxWare's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RxWare, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is RxWare worth?
- RxWare's last known valuation is $19.5M.
- How much has RxWare raised?
- RxWare has raised $13.8M in total funding across 2 recorded rounds.
- When did RxWare last raise?
- RxWare last raised in Aug 2025 (Early Stage VC), raising $6.1M.